EOLS Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
78.0M
-7.3%
84.1M
+15.0%
73.1M
-19.0%
90.3M
+30.9%
69.0M
Cost of Revenue
27.3M
+1.3%
26.9M
+11.0%
24.2M
-21.8%
31.0M
+34.1%
23.1M
Gross Profit
50.7M
-11.4%
57.2M
+16.9%
48.9M
-17.5%
59.3M
+29.3%
45.8M
Operating Expenses
59.1M
-2.2%
60.5M
+8.5%
55.7M
+1.2%
55.1M
-4.0%
57.3M
R&D
3.0M
+59.6%
1.9M
-15.5%
2.2M
-35.7%
3.5M
+70.1%
2.0M
SG&A
52.9M
-7.2%
57.1M
+9.8%
52.0M
-4.9%
54.7M
+3.5%
52.8M
Operating Income
-8428000
-155.9%
-3293000
+51.9%
-6848000
-262.3%
4.2M
+136.7%
-11500000
EBITDA
-6044000
-531.6%
-957000
+78.7%
-4502000
-169.5%
6.5M
+179.9%
-8106000
Net Income
-12516000
-55.4%
-8052000
+24.6%
-10674000
-8310.8%
130.0K
+100.8%
-15737000
EPS (Basic)
$-0.19
-58.3%
$-0.12
+25.0%
$-0.16
$0.00
+100.0%
$-0.24
EPS (Diluted)
$-0.19
-58.3%
$-0.12
+25.0%
$-0.16
$0.00
+100.0%
$-0.24
Shares (Diluted)
66.1M
+0.2%
65.9M
+1.1%
65.2M
+0.4%
64.9M
+0.3%
64.7M
Evolus (EOLS) — Financials